BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Guo F, Mead J, Aliya N, Wang L, Cuconati A, Wei L, Li K, Block TM, Guo JT, Chang J. RO 90-7501 enhances TLR3 and RLR agonist induced antiviral response. PLoS One 2012;7:e42583. [PMID: 23056170 DOI: 10.1371/journal.pone.0042583] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Harsini S, Beigy M, Akhavan-sabbagh M, Rezaei N. Toll-like receptors in lymphoid malignancies: Double-edged sword. Critical Reviews in Oncology/Hematology 2014;89:262-83. [DOI: 10.1016/j.critrevonc.2013.08.010] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
2 Hong T, Park K, Choi E, Hahn J. Ro 90-7501 inhibits PP5 through a novel, TPR-dependent mechanism. Biochemical and Biophysical Research Communications 2017;482:215-20. [DOI: 10.1016/j.bbrc.2016.11.043] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
3 Damm J, Wiegand F, Harden LM, Wenisch S, Gerstberger R, Rummel C, Roth J. Intraperitoneal and subcutaneous injections of the TLR9 agonist ODN 1668 in rats: brain inflammatory responses are related to peripheral IL-6 rather than interferons. J Neuroimmunol 2014;277:105-17. [PMID: 25465287 DOI: 10.1016/j.jneuroim.2014.10.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
4 Federico S, Pozzetti L, Papa A, Carullo G, Gemma S, Butini S, Campiani G, Relitti N. Modulation of the Innate Immune Response by Targeting Toll-like Receptors: A Perspective on Their Agonists and Antagonists. J Med Chem 2020;63:13466-513. [PMID: 32845153 DOI: 10.1021/acs.jmedchem.0c01049] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 10.0] [Reference Citation Analysis]
5 Sanchez David RY, Combredet C, Sismeiro O, Dillies MA, Jagla B, Coppée JY, Mura M, Guerbois Galla M, Despres P, Tangy F, Komarova AV. Comparative analysis of viral RNA signatures on different RIG-I-like receptors. Elife 2016;5:e11275. [PMID: 27011352 DOI: 10.7554/eLife.11275] [Cited by in Crossref: 52] [Cited by in F6Publishing: 32] [Article Influence: 8.7] [Reference Citation Analysis]
6 Thomsen EA, Andersen S, Marqvorsen MHS, Skipper KA, Paludan SR, Mikkelsen JG. Single-Cell Monitoring of Activated Innate Immune Signaling by a d2eGFP-Based Reporter Mimicking Time-Restricted Activation of IFNB1 Expression. Front Cell Infect Microbiol 2022;11:784762. [DOI: 10.3389/fcimb.2021.784762] [Reference Citation Analysis]
7 Khiar S, Pietrancosta N, Vidalain PO. [Stimulating Type I interferon response with small molecules: revival of an old idea]. Biol Aujourdhui 2015;209:145-59. [PMID: 26514384 DOI: 10.1051/jbio/2015015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
8 Sanchez David RY, Combredet C, Najburg V, Millot GA, Beauclair G, Schwikowski B, Léger T, Camadro JM, Jacob Y, Bellalou J, Jouvenet N, Tangy F, Komarova AV. LGP2 binds to PACT to regulate RIG-I- and MDA5-mediated antiviral responses. Sci Signal 2019;12:eaar3993. [PMID: 31575732 DOI: 10.1126/scisignal.aar3993] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 7.3] [Reference Citation Analysis]
9 Chang J, Block TM, Guo J. The innate immune response to hepatitis B virus infection: Implications for pathogenesis and therapy. Antiviral Research 2012;96:405-13. [DOI: 10.1016/j.antiviral.2012.10.001] [Cited by in Crossref: 50] [Cited by in F6Publishing: 49] [Article Influence: 5.0] [Reference Citation Analysis]
10 Ma J, Zhang X, Soloveva V, Warren T, Guo F, Wu S, Lu H, Guo J, Su Q, Shen H, Solon E, Comunale MA, Mehta A, Guo JT, Bavari S, Du Y, Block TM, Chang J. Enhancing the antiviral potency of ER α-glucosidase inhibitor IHVR-19029 against hemorrhagic fever viruses in vitro and in vivo. Antiviral Res 2018;150:112-22. [PMID: 29253498 DOI: 10.1016/j.antiviral.2017.12.008] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
11 Lee K, Kim DE, Jang KS, Kim SJ, Cho S, Kim C. Gemcitabine, a broad-spectrum antiviral drug, suppresses enterovirus infections through innate immunity induced by the inhibition of pyrimidine biosynthesis and nucleotide depletion. Oncotarget 2017;8:115315-25. [PMID: 29383162 DOI: 10.18632/oncotarget.23258] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
12 Guo F, Zhao X, Gill T, Zhou Y, Campagna M, Wang L, Liu F, Zhang P, DiPaolo L, Du Y, Xu X, Jiang D, Wei L, Cuconati A, Block TM, Guo JT, Chang J. An interferon-beta promoter reporter assay for high throughput identification of compounds against multiple RNA viruses. Antiviral Res 2014;107:56-65. [PMID: 24792753 DOI: 10.1016/j.antiviral.2014.04.010] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
13 Khiar S, Lucas-Hourani M, Nisole S, Smith N, Helynck O, Bourgine M, Ruffié C, Herbeuval JP, Munier-Lehmann H, Tangy F, Vidalain PO. Identification of a small molecule that primes the type I interferon response to cytosolic DNA. Sci Rep 2017;7:2561. [PMID: 28566766 DOI: 10.1038/s41598-017-02776-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
14 Falci Finardi N, Kim H, Hernandez LZ, Russell MRG, Ho CM, Sreenu VB, Wenham HA, Merritt A, Strang BL. Identification and characterization of bisbenzimide compounds that inhibit human cytomegalovirus replication. J Gen Virol 2021;102. [PMID: 34882533 DOI: 10.1099/jgv.0.001702] [Reference Citation Analysis]
15 Zulauf KE, Kirby JE. Discovery of small-molecule inhibitors of multidrug-resistance plasmid maintenance using a high-throughput screening approach. Proc Natl Acad Sci U S A 2020;117:29839-50. [PMID: 33168749 DOI: 10.1073/pnas.2005948117] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
16 Lucas-Hourani M, Dauzonne D, Jorda P, Cousin G, Lupan A, Helynck O, Caignard G, Janvier G, André-Leroux G, Khiar S, Escriou N, Desprès P, Jacob Y, Munier-Lehmann H, Tangy F, Vidalain PO. Inhibition of pyrimidine biosynthesis pathway suppresses viral growth through innate immunity. PLoS Pathog 2013;9:e1003678. [PMID: 24098125 DOI: 10.1371/journal.ppat.1003678] [Cited by in Crossref: 98] [Cited by in F6Publishing: 86] [Article Influence: 10.9] [Reference Citation Analysis]